References and Notes
1
Rosini C.
Franzini L.
Raffaelli A.
Salvadori P.
Synthesis
1992,
503
2
McCarthy M.
Guiry PJ.
Tetrahedron
2001,
57:
3809
3
Joncour A.
Décor A.
Liu JM.
Tran ME.
Dau H.
Baudoin O.
Chem. Eur. J.
2007,
13:
5450
4
Baudoin O.
Guénard D.
Guéritte F.
Mini-Rev. Org. Chem.
2004,
1:
333
5
Décor A.
Monse B.
Martin MT.
Chiaroni A.
Thoret S.
Guénard D.
Guéritte F.
Baudoin O.
Bioorg.
Med. Chem.
2006,
14:
2314
6
Baudoin O.
Claveau F.
Thoret S.
Herrbach A.
Guénard D.
Guéritte F.
Bioorg. Med. Chem.
2002,
10:
3395
7
Pascal C.
Dubois J.
Guénard D.
Guéritte F.
J. Org. Chem.
1998,
63:
6414
8
Zavala F.
Guénard D.
Robin JP.
Brown E.
J. Med. Chem.
1980,
23:
546
9
Monovich LG.
Huérou YL.
Rönn M.
Molander GA.
J.
Am. Chem. Soc.
2000,
122:
52
10
Pu L.
Chem.
Rev.
1998,
98:
2405
11
Morita H.
Awang K.
Hadi AHA.
Takeya K.
Itokawa H.
Kobayashi J.
Bioorg. Med. Chem. Lett.
2005,
15:
1045
12
Pascal C.
Dubois J.
Guénard D.
Tchertanov L.
Thoret S.
Guéritte F.
Tetrahedron
1998,
54:
14737
13
Bringmann G.
Mortimer AJP.
Keller PA.
Gresser MJ.
Garner J.
Breuning M.
Angew.
Chem. Int. Ed.
2005,
44:
5384
14
Herrbach A.
Marinetti A.
Baudoin O.
Guénard D.
Guéritte F.
J. Org. Chem.
2003,
68:
4897
15
Broady SD.
Golden MD.
Leonard J.
Muir JC.
Maudet M.
Tetrahedron
Lett.
2007,
48:
4627
16
Büttner F.
Bergemann S.
Guénard D.
Gust R.
Seitz G.
Thoret S.
Bioorg. Med. Chem.
2005,
13:
3497
17
Bergemann S.
Brecht R.
Büttner F.
Guénard D.
Gust R.
Seitz G.
Stubbs MT.
Thoret S.
Bioorg. Med. Chem.
2003,
11:
1269
18
Beryozkina T.
Appukkuttan P.
Mont N.
Eycken EV.
Org. Lett.
2006,
8:
487
19
Maryanoff BE.
Zhang HC.
Cohen JH.
Turchi IJ.
Maryanoff CA.
Chem. Rev.
2004,
104:
1431
20
Zhao HW.
Su S.
Cui J.
Song XQ.
Qin X.
Li HL.
Yan H.
Zhong RG.
Hu LM.
Synlett
2010,
2557
21
General Procedure
for the Cyclisations of Compounds 8b-d
To
a well-stirred solution of compound 8b-d (1.0 equiv)in anhyd acetonewas added
TsOH (0.5 equiv) in one portion. The resulting reaction solution
wa s stir red at r.t. for 2-4 h. The reaction solution
was concentrated under reduced pressure, and the crude products
were purified with column chromatography on silica gel to afford 9b-d and 10b-d, individually.
Analytical Data of (2
R
)-9b
Mp 75-77 ˚C; [α]D
²³ -155.5
(c 1.0, CHCl3). ¹H
NMR (400 MHz, CDCl3): δ = 7.89 (dd, J = 7.6, 1.2 Hz, 1 H), 7.72-7.82 (m,
2 H), 7.29-7.49 (m, 5 H), 6.33 (br, 1 H), 4.21 (br, 1 H), 1.82
(br, 3 H), 1.58 (br, 9 H). ¹³C NMR
(100 MHz, CDCl3): δ = 169.1, 154.2,
133.5, 132.1, 130.7, 128.7, 128.7, 127.4, 126.4, 124.1, 123.6, 122.8,
81.6, 70.3, 55.0, 29.6, 28.3, 18.5, 16.9. ESI-HRMS: m/z calcd for C21H23N2O3 [M + H+]: 351.1700;
found: 351.1703. HPLC: t
R = 13.0
min [Chiralpak OD-H (25 cm × 0.46
cm), Daicel Chemical Ind., Ltd., hexane-i-PrOH
(50:1), 1.0 mL/min, >99% ee].
22 C27H26N2O3, M = 426.52,
orthorhombic, a = 9.920
(7), b = 11.644
(3), c = 19.686
(6) Å, V = 2273.9
(18) ų, T = 293
K, space group P212121, Z = 4, 4035
reflections measured, 3686 unique (R
int = 0.033)
which were used in all calculations. The final R1 = 0.0318
with wR2 = 0.0838.
The X-ray crystallographic data of compound (2S,12bS,M)-9d was deposited at the Cambridge Crystallographic
Data Centre (CCDC-773497).
23
Dutot L.
Gaucher A.
Wright K.
Wakselman M.
Mazaleyrat JP.
Oancea S.
Peggion C.
Formaggio F.
Toniolo C.
Tetrahedron:
Asymmetry
2006,
17:
363
24
Royer J.
Bonin M.
Micouin L.
Chem.
Rev.
2004,
104:
2311
25
IJzendoorn DR.
Botman PNM.
Blaauw RH.
Org. Lett.
2006,
8:
239
26
Speckamp WN.
Moolenaar NJ.
Tetrahedron
2000,
56:
3817
